A multi-dimensional sales network covers the whole country. More than 3,000 distributors and 600 marketing professionals bring Sihuan products to over 10,000 hospitals nationwide, serving tens of millions of patients.

More than 20,000 innovative academic promotion activities are held each year, and nearly 70,000 physicians are registered with the online medical academy — combining online and offline channels to create new academic momentum for Sihuan.

For core mature products, the Group actively advances evidence-based research on efficacy, safety, and new indications to extend product life cycles. After two years of effort, some key products have been included in Clinical Pathways.

Mature products continue to deepen and expand primary markets, fully unlocking untapped potential. The company also has a professional medical-aesthetics sales team and a nationwide aesthetics marketing network, with 50+ direct-sales teams and 20+ distributor teams. Team members come from leading pharmaceutical and medical-aesthetics companies in China and overseas, holding key marketing and training roles with more than 10 years of industry experience. Sales cover 330+ cities and 4,000+ medical-aesthetics institutions, with 100% coverage of the top 500 medical-aesthetics institutions.

The Group continues to vigorously promote professional academic activities nationwide to strengthen recognition among experts and the industry and raise brand awareness.

Core products have undergone multiple clinical efficacy and safety studies. The Group actively advances evidence-based medicine to support inclusion in diagnosis and treatment guidelines, expert consensuses, and clinical pathways. All major products have entered county-level Clinical Pathway Interpretations and Clinical Pathway Medication Interpretations.

As tender access expands across provinces, high-potential products rapidly penetrate new markets.

Seizing new local medical-insurance opportunities, the Group expects key products to enter more provincial reimbursement lists and quickly enter those markets.

Aligned with the national tiered healthcare policy, resources are guided toward primary care. While consolidating high-end markets, the Group focuses on second- and third-tier cities, small and medium-sized county hospitals, and community healthcare institutions.

The Group continues comprehensive, systematic training for internal marketing teams and distributors to raise overall professional standards and make marketing activities at every level more efficient.

Markets are segmented scientifically to further unlock product potential, with tailored strategies and goals for products at different market stages. Direct-sales teams are being built progressively for key products.